Investment Rating - The report maintains a "Buy" rating for the company, indicating a potential upside of 93.8% from the current price of 8.77toatargetpriceof17.00 [2][3]. Core Insights - The company's total revenue for Q1 2024 decreased by 4% year-over-year to 395million,aligningwithconsensusestimates.Non−GAAPnetincomealsofellby4107 million, exceeding consensus estimates by 24% [2]. - Advertising revenue showed a mixed performance, with a 5% decline year-over-year to 339million,primarilyduetopressureinthecosmeticsandbeautyverticals.However,domesticbeautybrandssawover501,836 million, FY23A was 1,760million,andFY24Eisprojectedat1,724 million, with a slight recovery expected in FY25E and FY26E [3][10]. - Adjusted net profit for FY22A was 540.1million,FY23Awas450.6 million, and FY24E is expected to be 447.4million,indicatingadeclineinprofitability[3][10].−Thereporthighlightsanon−GAAPoperatingprofitmargin(OPM)of31.82.1 billion, sufficient to cover upcoming debt obligations and shareholder return plans [2][3]. - The report notes a projected decline in non-GAAP OPM to 32.9% for FY24E, reflecting ongoing operational challenges [2][3].